Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Arnold R. Gammaiton"'
Publikováno v:
Epilepsia Open, Vol 9, Iss 1, Pp 300-313 (2024)
Abstract Objective In patients with Dravet syndrome (DS), fenfluramine reduced convulsive seizure frequency and provided clinical benefit in nonseizure endpoints (e.g., executive function, survival). In zebrafish mutant scn1 DS models, chronic fenflu
Externí odkaz:
https://doaj.org/article/2b6507ecce2d48699f0a03d19bb7e3d3
Autor:
Dagmar Amtmann, Alyssa M. Bamer, Rana Salem, Arnold R. Gammaitoni, Bradley S. Galer, Mark P. Jensen
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-7 (2021)
Abstract Background English versions of the University of Washington Caregiver Stress (UW-CSS) and Benefit (UW-CBS) Scales were developed in the United States (US) to measure impact on caregivers of caring for a child/children. Caregiving stress and
Externí odkaz:
https://doaj.org/article/dd34785cd77c47af824f360219c46ed0
Autor:
M. Scott Perry, Bradley S. Galer, Kelly G. Knupp, Michael Lock, Rima Nabbout, Berten Ceulemans, Anupam Agarwal, Elaine C. Wirrell, Joseph Sullivan, Robert M. Cortes, Antonio Gil-Nagel, Orrin Devinsky, Ronald Davis, Arnold R. Gammaiton, Gail Farfel, Tilman Polster
Publikováno v:
Epilepsy and behavior
Objective: Appetite disturbance and growth abnormalities are commonly reported in children with Dravet syndrome (DS). Fenfluramine (Fintepla) has demonstrated profound reduction in convulsive seizure frequency in DS and was recently approved for use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd20f48759345d60a0e7a651c36b7488
https://repository.uantwerpen.be/docstore/d:irua:8656
https://repository.uantwerpen.be/docstore/d:irua:8656